Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

XEPAMET TABLETS 400 mg

Approval Number

SIN08030P

Drug Name

XEPAMET TABLETS 400 mg

Product Name

XEPAMET TABLETS 400 mg

Approval Date

February 23, 1995

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

A02BA01

ATC Item Name

cimetidine

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

Ingredient Name

CIMETIDINE

Strength

400 mg

Drug MonographCimetidine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

XEPAMET TABLETS 400 mg - HSA Approval | MedPath